期刊文献+

自噬在破骨细胞中的调控作用 被引量:4

The regulation function of autophagy in osteoclast
原文传递
导出
摘要 自噬广泛存在于真核细胞中,是细胞基本的自我保护机制。破骨细胞是髓系来源的高度分化的多核巨细胞,具有多种生物学功能。在成骨细胞和骨细胞分泌的巨噬细胞集落刺激因子和RANKL(receptor activator of NF-κB ligand)的作用下,可促进破骨细胞的形成,对调控和维持骨骼正常代谢发挥作用。自噬作为保守的维持细胞稳态的重要作用机制,同样在骨细胞的形成和功能发挥过程中起着重要的作用。本文旨在总结破骨细胞的生物学作用,概括自噬对破骨细胞的形成及对其生物学作用的调控机制,并对自噬异常造成的骨相关疾病进行总结。 Autophagy, a cellular self-protection mechanism, exists in all eukaryocytes. Originated from bone marrow stem cells, osteoclasts are armed with multiple biological functions. Osteoclasts formation are promoted by macrophage colony-stimulating factor and receptor activator of NF-κB ligand(RANKL) secreted by osteoblasts and osteocytes, which are essential in regulating and maintaining the normal metabolism of bones. As a conservative fundamental mechanism to maintain cellular homeostasis, autophagy is also critical for the forming and function of osteoclasts. Our review will discuss the regulation of autophagy on biological function of osteoclasts and underlying mechanisms, and dysregulation of the autophagic response in the pathogenesis of bone-related disorders will also be included.
出处 《生命的化学》 CAS CSCD 2016年第3期354-358,共5页 Chemistry of Life
基金 国家自然科学基金项目(31590905) 上海市人才发展基金项目(201465)
关键词 自噬 破骨细胞 RANKL 调控作用 autophagy osteoclasts RANKL regulation function
  • 相关文献

参考文献1

二级参考文献1

共引文献13

同被引文献42

  • 1Charles JF,Aliprantis AO.Osteoclasts:more than‘bone eaters’[J].Trends Mol Med,2014,20:449-459.
  • 2Boyle WJ,Simonet Ws,Lacey DL.Osteoclast differentiation and activation[J].Nature,2003,423:337-342.
  • 3Drake MT,Clarke BL,Lewiecki EM.The pathophysiology and treatment of osteoporosis[J].Clin Ther,2015,37:1837-1850.
  • 4Gonciulea A,de Beur SJ.The dynamic skeleton[J].Rev Endocr Metab Disord,2015,16:79-91.
  • 5Cappariello A,Maurizi A,Veeriah V,et al.The great beauty of the osteoclast[J].Arch Biochem Biophys,2014,558:70-78.
  • 6Katagiri T,Takahashi N.Regulatory mechanisms of osteoblast and osteoclast differentiation[J].Oral Dis,2002,8:147-59.
  • 7Xu J,Wu HF,Ang ES,Yip K,et al.NF-kappaB modulators in osteolytic bone diseases[J].Cytokine Growth Factor Rev,2009,20:7-17.
  • 8Suda T,Takahashi N,Udagawa N,et al.Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families[J].Endocr Rev,1999,20:345-357.
  • 9Nikhil K,Sharan S,Roy P.A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NF kappa B and MAPK signaling in RAW264.7cells[J].Pharmacol Rep,2015,67:1264-1272.
  • 10Xiong Q,Zhang L,Xin L,et al.Proteomic study of different culture medium serum volume fractions on RANKL-dependent RAW264.7cells differentiating into osteoclasts[J].Proteome Sci,2015,13:16.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部